ITCI
Intra-Cellular Therapies, Inc. (ITCI)
$54.222.59%▲
Market is closedMarket is closed – opens on 8 PM, 01 Dec 2022
– opens on 8 PM, 01 Dec 2022
Key Stats
$51.5
Day's Range
$54.23
$34.43
52-Week Range
$66.0
| Returns | |
| 1 month return | 18.05% |
| 3 month return | 7.32% |
| 1 year return | 40.69% |
| 5 year return | 253.34% |
Company Information
Intra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases.
| Organization | Intra-Cellular Therapies, Inc. |
| Employees | 512 |
| CEO | Dr. Sharon Mates Ph.D. |
| Industry | Health Technology |
Analyst Recommendation
based on 10 analysts ratings
Buy
100%
Buy
0%
Hold
0%
Sell
Based on 10 Wall street analysts offering stock ratings for Intra-Cellular Therapies, Inc.(by analysts ranked 0 to 5 stars)
Analyst Forecast
What analysts predicted
Upside of 26.69%Current
$54.22
Target
$68.69
Recommendation Trend
Based on 10 analyst
| Current | 1M Ago | 3M Ago | |
| Buy | 10 | 16 | 18 |
| Hold | 0 | 3 | 2 |
| Sell | 0 | 0 | 0 |
| Consensus | BUY | BUY | BUY |
Company Financials
Highlights
| Market Capitalization | 5.0B |
| Book Value | $7.24 |
| Dividend Share | 0.0 |
| Dividend Yield | 0.0% |
| Earnings Per Share (EPS) | -3.61 |
| PEG Ratio | 0.0 |
| Wall Street Target Price | 68.69 |
Valuation
| Trailing PE | 0.0 |
| Forward PE | 0.0 |
| Price/Book (mrq) | 7.21 |
| Enterprise Value | 4.3B |
| Enterprise Value/Revenue | 23.17 |
| Enterprise Value/Ebitda | -14.38 |
Technicals
| Beta | 1.14 |
| 50 Day MA | 48.05 |
| 200 Day MA | 53.79 |
Institutional Holdings
FMR Inc
10.91%
Vanguard Group Inc
8.57%
Wasatch Advisors Inc.
5.54%
Wellington Management Company LLP
5.45%
Bellevue Group AG
3.52%
AllianceBernstein L.P.
2.23%
Discover more
Frequently Asked Questions
What is Intra-Cellular Therapies, Inc. share price today?
Can Indians buy Intra-Cellular Therapies, Inc. shares?
How can I buy Intra-Cellular Therapies, Inc. shares from India?
Can Fractional shares of Intra-Cellular Therapies, Inc. be purchased?
What are the documents required to start investing in Intra-Cellular Therapies, Inc. stocks?
What are today’s High and Low prices of Intra-Cellular Therapies, Inc.?
What are today’s traded volumes of Intra-Cellular Therapies, Inc.?
What is today’s market capitalisation of Intra-Cellular Therapies, Inc.?
What is the 52 Week High and Low Range of Intra-Cellular Therapies, Inc.?
How much percentage Intra-Cellular Therapies, Inc. is down from its 52 Week High?
How much percentage Intra-Cellular Therapies, Inc. is up from its 52 Week low?
What are the historical returns of Intra-Cellular Therapies, Inc.?
Who is the Chief Executive Officer (CEO) of Intra-Cellular Therapies, Inc.?
Trading and brokerage services provided by
Banking and Remittance services provided by
Technology services provided by : Finzoomers Services Private Limited
Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*